1005782-23-9

Basic information

• Product Name: N-[3-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)phenyl]-1,3-thiazole-2-carboxamide
• Synonyms: N-[3-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)phenyl]-1,3-thiazole-2-carboxamide
• CAS NO: 1005782-23-9
• Molecular Weight: 420.451
• Mol File: 1005782-23-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[3-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)phenyl]-1,3-thiazole-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)phenyl]-1,3-thiazole-2-carboxamide(1005782-23-9)
• EPA Substance Registry System: N-[3-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)phenyl]-1,3-thiazole-2-carboxamide(1005782-23-9)

Safety Data

• Hazardous Substances Data: 1005782-23-9(Hazardous Substances Data)

Upstream product

• 30216-57-0 1,3-thiazole-2-carbonyl chloride 
• 1005777-50-3 N-[6-(3-aminophenoxy)imidazo[1,2-b]pyridazine-2-yl]cyclopropanecarboxamide 

Relevant articles and documents

FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF

The present invention provides a fused heterocyclic derivative having a potent kinase inhibitory activity and use thereof. A compound represented by the formula (I): wherein each symbol is as defined in the specification, except a particular compound, or a salt thereof, and a pharmaceutical agent containing the compound or a prodrug thereof, which is a kinase (VEGFR, VEGFR2, PDGFR, Raf) inhibitor, an angiogenesis inhibitor, an agent for the prophylaxis or treatment of cancer, a cancer growth inhibitor or a cancer metastasis suppressor.